Build AI Agents for Life Sciences with NVIDIA BioNeMo and Nebius in partnership with J.P.Morgan

AI agents are transforming how life sciences teams approach research, from automating literature analysis to accelerating drug discovery and computational biology workflows. But what does it take to build these systems in practice?

Join NVIDIA, J.P. Morgan and Nebius for an interactive workshop on how the BioNeMo Agent Toolkit is helping developers and life sciences teams build AI-powered workflows for biology, chemistry, drug discovery, and translational research.

Designed for both technical builders and startup leaders, this session will give developers a closer look at building with BioNeMo while helping founders understand where agentic AI can create leverage across R&D.

In this workshop, you’ll learn:

  • What the NVIDIA BioNeMo Agent Toolkit is and how it works
  • How AI agents can accelerate life sciences research and drug discovery
  • How to deploy and scale BioNeMo on Nebius AI Cloud
  • Best practices for building production-ready AI workflows for biotech and pharma
  • Where startups can apply agentic AI to create competitive advantage

If you are building in biotech, pharma, digital biology, lab automation, computational chemistry, or AI for life sciences, this workshop will help you understand what is now possible with NVIDIA BioNeMo.

Our speakers

Ilya Burkov

Global Head of Life Science and Healthcare Growth at Nebius

Laura Boykin Okalebo

Life Sciences Solutions Partner at Nebius

Elizabeth Scallon

Director, Healthcare & Life Science AI Startups at NVIDIA

Jun Deng

Executive Director at J.P. Morgan

Mahan Salehi

Product Manager Lead at NVIDIA

René Schönfelder

Solutions Architect at Nebius

Chelsea Sumner

Healthcare AI Startups Lead at NVIDIA

Register to get the invitation and the recording

Try Nebius AI Cloud console today

Get immediate access to NVIDIA® GPUs, along with CPU resources, storage and additional services through our user-friendly self-service console.